| Spectrum Pharmaceuticals Files IND Application with US FDA for SPI-014 - FierceBiotech |
|
|
FierceBiotech According to the United States Renal Data System, there were more than 571 thousand patients with ESRD in the United States in 2009. Currently marketed therapies for treating hyperphosphatemia include polymer-based and lanthanum-based phosphate binders |